Status:
COMPLETED
A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Uterine Cancer
Cervix Uteri Nos
Eligibility:
FEMALE
18-60 years
Brief Summary
The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD surviv...
Eligibility Criteria
Inclusion
- Pathology confirmed GTD by MSKCC
- Sufficient proficiency in the English language to respond to quality of life surveys
- Age ≥ 18 years
- Benign or malignant disease
- Treated with surgery and/or chemotherapy or observation
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00706875
Start Date
June 1 2008
End Date
April 1 2018
Last Update
April 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065